BCL2 and hepatocellular carcinoma: It is also well-known that HCC exhibits resistance to chemotherapy or radiotherapy and recent studies have revealed that the emerging resistance of HCC to conventional therapies resulted from the induction of resistance-associated protein 2 and anti-apoptotic Bcl-2 [16, 17].